{"nct_id":"NCT06752681","title":"To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors","status":"RECRUITING","status_verified_date":"2025-03","start_date":"2024-11-18","start_date_type":"ACTUAL","primary_completion_date":"2027-12","primary_completion_date_type":"ESTIMATED","completion_date":"2028-12","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["DAWN"]}